Statistics for A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY)
Total visits
| views | |
|---|---|
| A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY) | 34 |
Total visits per month
| views | |
|---|---|
| July 2022 | 2 |
| August 2022 | 3 |
| September 2022 | 2 |
| October 2022 | 0 |
| November 2022 | 2 |
| December 2022 | 0 |
| January 2023 | 1 |
| February 2023 | 0 |
| March 2023 | 1 |
| April 2023 | 0 |
| May 2023 | 1 |
| June 2023 | 0 |
| July 2023 | 0 |
| August 2023 | 0 |
| September 2023 | 0 |
| October 2023 | 0 |
| November 2023 | 2 |
| December 2023 | 0 |
| January 2024 | 1 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 1 |
| June 2024 | 2 |
| July 2024 | 0 |
| August 2024 | 4 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 3 |
| August 2025 | 1 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 1 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 2 |
| June 2026 | 0 |
| July 2026 | 1 |
| August 2026 | 0 |
| September 2026 | 4 |
| October 2026 | 0 |
Top country views
| views | |
|---|---|
| United States | 11 |
| Japan | 4 |
| Turkey | 4 |
| China | 2 |
| Hong Kong SAR China | 2 |
| Iran | 2 |
| Sweden | 2 |
| Australia | 1 |
| Finland | 1 |
| Mongolia | 1 |
Top city views
| views | |
|---|---|
| Tokyo | 4 |
| Istanbul | 3 |
| San Jose | 2 |
| Ankara | 1 |
| Atlanta | 1 |
| Dallas | 1 |
| Gurnee | 1 |
| Hong Kong | 1 |
| Houston | 1 |
| Los Angeles | 1 |